Live tape
Top 8, mentions 7d7,350SPCX1,444 mentions▲ +0.09GOOGL1,345 mentions▲ +0.05NVDA1,196 mentions▲ +0.09MSFT840 mentions▲ +0.04QQQ693 mentions▲ +0.08META639 mentions▲ +0.04SPY601 mentions▲ +0.06AMZN592 mentions▲ +0.07

Equity · Healthcare

BMY

NYSE

Bristol-Myers Squibb Company

$59.11 −0.76% vs prior close Finazon · prior-day close, indicative (IEX-derived, not the official close) · Oct 9, 2026

Reddit mentioned BMY 5 times in the 30 days to 11 October 2026, across 3 of the communities we track. All of them were scored for sentiment: 40% read bullish, 0% bearish and 60% neither. Reddit data updated 11 October 2026.

Price · Chart
64 sessions
$70 $55 13 Jul 9 Oct

The line runs $59.36 on 13 July through $59.11 on 9 October, on a scale from $55 to $70. Days the market did not trade hold the previous close, flat.

Market cap $120.7B
P/E (TTM) 13.0
52-week range $42.64 – $68.08
Avg volume 675.4K
Mentions · 30d 5
Net sentiment +0.17

as of Oct 9, 2026

BMY · crowd attention × price

Share ↗
5 mentions

Day6 Oct 2026

MENTIONS10–2 / day
PRICE$59.58$58–$66
BMY over the last 30 days, plotting daily Reddit mentions as bars, left-hand scale; the daily closing price as a line on its own right-hand scale, solid across consecutive trading days, held flat and diagonally hatched over days the market was closed.per day012usd$58$60$62$64$6612 Sep19 Sep27 Sep4 Oct11 Oct
BMY over the last 30 days, plotting daily Reddit mentions as bars, left-hand scale; the daily closing price as a line on its own right-hand scale, solid across consecutive trading days, held flat and diagonally hatched over days the market was closed.12 Sep27 Sep11 Oct
The Distributed Sentinel 11 Oct 2026

BMY drew 5 Reddit mentions over the 30 days to 11 October 2026

This chart in words

The chart plots daily Reddit mentions of BMY over the 30 days to 11 October 2026: 5 in total, busiest on 17 September with 1, and 1 on the last day counted. The line is the daily close over the same window: $64 on 14 September, $59.11 on 9 October. Of those days, 20 were trading sessions and the other 10 are hatched on the chart. On 8 of them no session took place, and the last close before it is carried forward rather than plotted; on 2 of them no session took place, and this window holds no earlier close to carry forward.

Crowd sentiment on BMY · 30d

n = 5 scored · Method
BMY

40% bullish

Overall market sentiment

54% bullish

BMY reads 14 points less bullish than overall market sentiment. Same measure; same 30-day window.

Where BMY is discussed

(30d)
r/wallstreetbets 60% 3 +0.24
r/investing 20% 1 +0.02
r/cryptocurrency 20% 1 +0.10

BMY insider trades

SEC Form 4 · last 90 days · newest reported trade 9 Sep 2026
Open-market buys 0
Open-market sells 2
Net sold $437K
Non-trade filings 8
Date Insider Type Shares Value
09 Sep 2026 Massacesi Cristian EVP,Chief Med Offr,Head of Dev Sell 6,249 $403K
25 Aug 2026 Holzer Phil M SVP and Controller Sell 500 $34K

Compensation mechanics Share grants, option exercises, tax withholding and transfers. They reach the same Form 4 as a trade, but they are not the insider buying or selling on the open market, so no purchase or sale value applies to them.

Date Insider Type Shares Value
02 Oct 2026 Gallman Cari EVP, General Counsel Option exercise 4,559
02 Oct 2026 Gallman Cari EVP, General Counsel Tax withheld 2,332 $143K
01 Sep 2026 Short Bartie Wendy EVP, Corporate Affairs Option exercise 1,236 $83K
01 Sep 2026 Short Bartie Wendy EVP, Corporate Affairs Tax withheld 633 $42K
01 Aug 2026 Gallman Cari EVP, General Counsel Option exercise 1,061
01 Aug 2026 Gallman Cari EVP, General Counsel Tax withheld 543 $35K
01 Aug 2026 Massacesi Cristian EVP,Chief Med Offr,Head of Dev Option exercise 51,172
01 Aug 2026 Massacesi Cristian EVP,Chief Med Offr,Head of Dev Tax withheld 26,175 $1.71M

BMY reported financials

SEC EDGAR XBRL SEC EDGAR

BMY reported revenue of $48.2B for the fiscal year ended 31 Dec 2025. Net income over the same period was $7.1B.

Figure Reported Period
Revenue $48.2B 31 Dec 2025 fiscal year
Net income $7.1B 31 Dec 2025 fiscal year
Diluted EPS $3.46 31 Dec 2025 fiscal year
Total assets $87.6B 30 Jun 2026 at period end
Total equity $22.3B 30 Jun 2026 at period end

BMY earnings

SEC EDGAR
Date Period EPS Revenue
30 Jun 2026 Q2 2026 $1.62 $12.97B
31 Mar 2026 Q1 2026 $1.31 $11.49B
31 Dec 2025 FY 2025 $3.46 $48.19B
30 Sep 2025 Q3 2025 $1.08 $12.22B
30 Jun 2025 Q2 2025 $0.64 $12.27B
31 Mar 2025 Q1 2025 $1.20 $11.20B
31 Dec 2024 FY 2024 −$4.41 $48.30B
30 Sep 2024 Q3 2024 $0.60 $11.89B

Next report no date announced in SEC filings yet

Reported figures & scheduled dates · SEC EDGAR filings

BMY institutional holders

SEC Form 13F SEC EDGAR

10 of the 45 institutional funds we track reported a BMY position for the quarter ended 30 Jun 2026 — a combined $2.6B; the latest of those filings landed 02 Sep 2026.

Fund Action Shares Value
AQR Capital Management Held (±25%) −7.7% shares 27,357,486 $1.6B
Two Sigma Investments Held (±25%) −12.6% shares 10,085,383 $581.1M
Man Group Held (±25%) −17.3% shares 4,682,000 $269.8M
Citadel Advisors Held (±25%) +5.2% shares 1,572,329 $90.6M
Millennium Management Trimmed −88.5% shares 752,576 $43.4M
D. E. Shaw & Co. Added +80.5% shares 559,407 $32.2M
Fisher Asset Management Held (±25%) −14.9% shares 173,404 $10.0M
Balyasny Asset Management Trimmed −25.6% shares 88,288 $5.1M
GAMCO Investors Held (±25%) −5.0% shares 82,671 $4.8M
Marshall Wace Trimmed −99.6% shares 15,169 $874K

BMY fails-to-deliver

SEC CNS data SEC

On 03 Sep 2026, 280 shares of BMY failed to deliver (about $19K) — the latest of 2 consecutive trading days with recorded fails.

Settlement date Shares failed Notional % of shares out
03 Sep 2026 280 $19K <0.001%
02 Sep 2026 242 $16K <0.001%

Congressional trades in BMY

STOCK Act disclosures House disclosures

The most recent congressional trade disclosed in BMY is a purchase by Gilbert Ray Cisneros, Jr. (house, CA), dated 19 Dec 2025.

Date Member Type Amount
19 Dec 2025 filed 12 Jan 2026 Gilbert Ray Cisneros, Jr. house · Democrat–CA Purchase $1K–$15K
18 Dec 2025 filed 15 Jan 2026 Julie Johnson house · Democrat–TX Sale $1K–$15K
13 Nov 2025 filed 11 Dec 2025 Julie Johnson house · Democrat–TX Sale $1K–$15K
12 Nov 2025 filed 15 Dec 2025 Gilbert Ray Cisneros, Jr. house · Democrat–CA Purchase $1K–$15K
14 Aug 2025 filed 11 Sep 2025 Julie Johnson house · Democrat–TX Sale $1K–$15K
24 Jun 2025 filed 03 Jul 2025 Virginia Foxx house · Republican–NC Sale $1K–$15K
12 May 2025 filed 22 Jun 2025 Jefferson Shreve house · Republican–IN Sale $15K–$50K
28 Apr 2025 filed 13 Jan 2026 Julia Letlow house · Republican–LA Sale $1K–$15K

BMY — frequently asked questions

From live data

How often is BMY mentioned on Reddit?

BMY was mentioned 1 times in the last 7 days across the finance subreddits we track, and 5 times over the trailing 30 days.

Is Reddit bullish or bearish on BMY?

Across 5 classified BMY mentions in the last 30 days, 40% read bullish, 0% bearish and 60% neutral. Crowd sentiment is a social signal, not investment advice.

When did BMY last report earnings?

Bristol-Myers Squibb Company (BMY) last reported earnings on 30 Jun 2026 for Q2 2026, per SEC filings.

Are BMY insiders buying or selling?

SEC Form 4 filings over the last 90 days show 0 buys and 2 sells by BMY insiders on the open market. A further 8 filings were grants, awards, gifts or exercises rather than open-market trades.

Who is the CEO of Bristol-Myers Squibb Company?

Giovanni Caforio leads Bristol-Myers Squibb Company (BMY) as chief executive.

What exchange is BMY listed on?

Bristol-Myers Squibb Company trades on NYSE under the ticker BMY.

Answers are generated from the live figures on this page — Reddit crowd data, SEC filings and open company records — and update as the data does.

Sources

  1. Finazonprior-day close, indicative (IEX-derived, not the official close), some closes dollar-rounded at the source
  2. TradingViewthe price chart widget, drawn by TradingView from their own data
  3. RedditReddit ingest across the tracked finance subreddits
  4. SEC EDGARSEC EDGAR XBRL company facts · latest period ended 30 Jun 2026
  5. SEC EDGARSEC EDGAR 13F filings
  6. SECSEC fails-to-deliver (CNS) data
  7. House disclosuresU.S. House of Representatives financial disclosures
  8. SEC EDGARValuation computed from SEC EDGAR filings
  9. Wikipediatext of the lead paragraph, licensed CC BY-SA 4.0 (https://creativecommons.org/licenses/by-sa/4.0/) — https://en.wikipedia.org/wiki/Bristol_Myers_Squibb